Bio-Works Technologies is a biotechnology company. The company develops products that separate and purify molecules in the production of drugs. The technology is based on chromatography that aims to handle the drug substance. Customers are found in the European market where products are sold through distribution partners and to companies in the pharmaceutical industry. They are also sold to research institutes and universities. The company was founded in 2006 and is headquartered in Uppsala.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Staffan Persson | 18,79 | 18,79 | 2024-06-26 |
| Erik Åfors | 15,72 | 15,72 | 2024-06-26 |
| Dariush Hosseinian | 4,01 | 4,01 | 2023-10-02 |
| Avanza Pension | 3,85 | 3,85 | 2024-06-26 |
| Rhenman Partners Asset Management AB | 3,63 | 3,63 | 2024-03-31 |
| Peter von Ehrenheim | 3,29 | 3,29 | 2024-06-26 |
| Laurent Leksell med bolag | 2,52 | 2,52 | 2024-06-26 |
| Olof Mathias Malmgren | 1,87 | 1,87 | 2024-06-26 |
| Nordnet Pensionsförsäkring | 1,64 | 1,64 | 2024-06-26 |
| Futur Pension | 1,45 | 1,45 | 2022-09-30 |
2024-07-29 Delårsrapport Q3 2024
2024-08-02 Delårsrapport 2024-Q2
2025-02-21 Bokslutskommuniké 2024
